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Scientists in the field of chemical carcinogenesis as
well as cancer epidemiology have long supported the concept of
environmental causation of cancer. Human cancer can result
from environmental factors such as cigarette smoking,
radiation, industrial pollutants, occupational exposures,
pesticides, diet, viruses, pharmaceutical agents, and other
life-style factors (Davis, 1989).
Many naturally occurring and anthropogenic chemical
carcinogens are ubiquitous in the environment. Miller
reported that a high proportion of human cancer is of
environmental origin (Miller, 1970). It has also been stated
that the chemical carcinogens in our total environment,
through lifetime exposure to small amounts of these compounds,
may rank as major causes of human cancer (Miller, 1970;
Pruessmann, 1976). These small levels of particular
carcinogens may actually be "subthreshold" (Pruessmann, 1976).
However, this occurrence does not refute environmental
carcinogenesis. Cancer in man is multifactorial.
Syncarcinogenic activity, and enhancing and modifying factors
influencing carcinogenic processes seem to be the central
problem of environmental carcinogenesis (Pruessmann, 1976).
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Compounds can influence carcinogenicity in several ways
(Davis, 1989). These include; (1) covalent binding of a
competing compound with DNA to block or otherwise influence
the initiation of carcinogenesis by the toxic compound; (2)
trapping or inactivating compounds that deter tumor promotion;
(3) blotransforming parent compounds; (4) chemical or physical
conversion of metabolites by active catalysis or other
physical alteration of carcinogens through food preparation or
digestive processes (Davis, 1989). An important aspect of
carcinogenesis is that experimentation indicates that the
mechanistic action of most environmental carcinogens undergo
biotransformation (Miller, 1970). In this respect, compounds
such as aflatoxln and safrole appear to be precarcinogens
(Fig. 1) since they are metabolized to carcinogenic and
reactive compounds (Miller, 1970).
The biotransformation reactions may be divided into two
phases. Phase I of drug/xenobiotic metabolism is concerned
with the oxidative and reductive processes involved with the
elimination of exogenous/endogenous compounds. The microsomal
cytochrome P-450 dependent monooxygenase enzyme oxidation
system is instrumental in this respect. This enzyme system
requires NADPH in the presence of molecular oxygen to confer
its activity, l.e. to oxidize at aliphatic and aromatic
carbon, nitrogen and sulfur (Wlslocki et al., 1980). However,
the cytochrome P-450 oxidation system yields extremely
reactive and hence potentially toxic substances such as free
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FIGURE 1; Some naturally occuring precarcinogens which are
converted in man as well as animals into

















radicals, epoxides, and peroxides. (Wislocki et al., 1980).
The action of the Phase II enzymes may render these
potentially toxic compounds less reactive.
The phase II reactions of drug metabolism involve the
conjugation reactions. Glutathione S-transferase, a phase II
enzyme, is a major contributor and catalyzes the subsequent
conjugation of the toxic compound with glutathione (Wislocki
et al., 1980). Its product, GS-X (where GS denotes
glutathione and X denotes a potential lipophilic electrophile)
is rendered more water soluble and less reactive than the
xenobiotic's free form (Fig. 2). Elimination of the foreign
compound follows via the bile since S-conjugates are anions
(Chasseaud, 1974).
If GST is unable to render these carcinogens inactive,
then they may Interact with informational macromolecules and
ultimately induce malignant cancers. This mechanism (Fig. 3)
would generally follow that of a Sjj2 reaction in which a
relatively positive or electrophilic atom in the carcinogen
combines with the relatively negative or nucleophilic atoms of
the molecules attacked in cells (Miller, 1970; Miller &
Miller, 1971).
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FIGURE 2: Catalysis of the conjugation of glutathione to
organic electrophiles such as l-chloro-2,4-


















FIGURE 3: Possible mechanisms of carcinogenesis by the
ultimate carcinogenic electrophilic reactants
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Once the malignant cancers are Induced, irreversible
processes occur during the initiation stage of preneoplasia.
Alterations of specific genes, including the activation of
proto-oncogenes, occur (Sato, 1989). The outcome is the
development of tumor cells possessing elevated glutathione s-
transferase activity (Sato, 1989; Hayes et al., 1990; Rao,
1992) .
The dilemma arises in attempting to treat these cells.
Many chemotherapeutic agents are also inactivated by
glutathione (Griffith, 1989). Hence, these carcinostatic
compounds may serve as potential substrates of GST and, as
such, are rendered ineffective. However, these tumors can be
sensitized to the effects of the chemoprotectant by minimizing
GST activity (Griffith, 1989).
Rationale
The purpose of this study is to examine the Interaction
of GST with its substrates via kinetic analysis. The
generated results would allow the proposal of a plausible
reaction mechanism. As such, the form of enzyme that would
best interact with a putative chemotherapeutic agent can be
determined. Hence, the chemoprotectant can be chemically




As reported by Meister (1980), in 1879 Baumann, Preusse
and Jaffe demonstrated that the administration of bromobenzene
and chlorobenzene to canines resulted in urinary excretion of
compounds referred to as mercapturic acids. S-substituted
derivatives of N-acetylcysteine are referred to as mercapturic
acids (Boyland and Chasseaud, 1969). The source of the
cysteine residue was thought to have derived from dietary
proteins. However, in 1937, Stekol refuted this idea upon
supplementing the food of animals with glutathione (reported
by Boyland and Chasseaud, 1969). There was no net increase in
mercapturic acid formation resulting from the diet or from
depletion of cysteine from tissue proteins. Several
mechanisms of mercapturic acid formation were proposed
(Stekol, 1939; Smith et al., 1950; Mills and Wood, 1956;
Barnes et al., 1959; Bray et al., 1959; Waelsch, 1930; Brand
and Harris, 1933). It was Booth and his colleagues in 1961,
who isolated a protein/enzyme that catalyzed conjugation of
glutathione with foreign compounds. Including some that were
metabolized to mercapturic acids. Grover and Sims (1964)
referred to this enzyme as glutathione S-aryltransferase
because of its apparent specificity for glutathione and
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compounds possessing an aromatic ring. Several other enzymes
capable of catalyzing glutathione conjugation were later
discovered and purified. These enzymes are collectively known
as glutathione S-transferases.
Glutathione S-transferases (GSTs) are comprised of (1)
glutathione S-aryltransferase, (2) glutathione S-
epoxldetransferase, (3) glutathione S-alkyltransferase, (4)
glutathione S-aralkyltransferase, and (5) glutathione S-
alkenetransferase (Boyland and Chasseaud, 1969). However,
Jakoby (1980) contend that the term "Glutathione Transferases"
is a misnomer since these enzymes should not be viewed as
participating in only the transfer of glutathione, but rather
as proteins that catalyze any reaction in which glutathione
thiolate anion participates. GSTs catalyze the conjugation of
GSH to xenobiotics and other electrophilic compounds
possessing aromatic and other cyclic rings that have labile
nitrogen or halogen groups. These proteins may exist in
soluble and membrane-bound forms. Glutathione S-transferases
collectively represent a family of dimeric and trimeric
enzymes which have been isolated in the cytosol and microsome,
respectively (Hayes et al., 1991; Adams and Sikakana, 1990).
The membrane-bound microsomal GST, which is less active than
cytosolic GST, represents only one type while all the other
types can be found in the cytosol (Meikle, et al., 1991).
Hence, only the cytosolic form will be considered. These
enzymes may be found in various species, from Escherichia coll
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to humans, and may exist as homodimers or heterodimers
(Pickett, 1989; Adams and Sikakana, 1990; Ivanetich and Goold,
1989). Each subunit is found to have a molecular weight
ranging from 17kd to 26kd and is characterized on the basis of
its isoelectric points (Hayes et al., 1991; Habig and Jakoby,
1981). Approximately eleven subunits have been identified in
the rat and, in the nomenclature used, each subunit is given
a number in the chronological order of its characterization
(Jakoby et al., 1984). The complete amino acid sequences have
been deduced for subunits 1 (Pickett et al., 1984; Lai et al.,1984), 2 (Telakowski-Hopkins et al., 1985), 3 (Ding et al.,1985), 4 (Lai et al., 1988), 6 (Abramowltz and Llstowsky,
1987) and 7 (Suguoka et al., 1985). Mannervik et al., (1985)
and Mannervik (1985) report that the sequences, based on
structural data (Table 1), suggest that the subunits fall into
three categories or classes; the alpha class (subunits 1 and
2), the mu class (subunits 3, 4, and 6), and the pi class
(subunit 7).
The mode of action of these enzymes are presently
unclear. Unlike other prominent conjugation processes, GSH
conjugation does not require utilization of ATP (Chasseaud,
1979). Al-Kassab et al., (1963) suggested that rat GST
provided a "charged" GSH for conjugation with an electrophile.
The rate of the non-enzymatic reaction of the electrophilic
10
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Lacks homology with any of the cytosolk isoiymes
*Gas8 alpha also comprises humaa transferases <(•( and mouse transferase ML These
proteins are amino-terminailj blocked and are not listed owing to lack of sequence
information.
Italicized residues indicate tentative assignments or initiator methionine.
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substrate with GSH increases proportionately to the increase
of ionized GSH (Chasseaud, 1979). This outcome, therefore,
suggests that GS~ is the reacting nucleophile. Keen et al.,
(1976) reported that human (alpha class; see Table 1) p and ft
GSTs promote ionization of the sulfhydryl group of GSH by
lowering its pK (pK = 9.2) and thereby increasing its
nucleophilicity. In addition, GST would bind the electrophile
promoting preferential interaction with the GS“ anion.
Reduction of the pK of the GSH thiol is thought to be a major
contributor to GST's mode of action. Awasthi et al., (1987)
contend that a single histidine residue is responsible for
this reduction since substitution of a single histidine
residue with a basic group resulted in the loss of human ^
(Table 1) GST activity. It has also been suggested that an
arginine residue is associated with GSH binding and anion
recognition (Schasteen et al., 1983). On the other hand, Kong
et al., (1992) reported that a tyrosine residue on human GST
is responsible for GSH ionization.
Characterization of the kinetic mechanism of GST is
equally perplexing. Investigators have reported that studies
on YaYa GST from male Sprague-Dawley rats suggest that the
kinetic mechanism of substrate addition is likely to be random
(Schramm et al., 1984). In addition, competitive inhibition
studies reveal a single binding site for a product analog.
This occurrence is consistent with the presence of a single
catalytic site (Schramm et al., 1984). Danielson and
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Mannervik (1988) reported that GST from rat liver exhibits
paradoxical inhibition which may be explained by substrate-
inhlbltor-enzyme complexes in a random-order sequential
mechanism. However, experimental support for kinetically
significant conformational changes under steady-state
conditions is lacking. Ivanetich and Goold (1989) also
endorsed the rapid random equilibrium sequential B1 B1
mechanism for human placental glutathione S-transferase
(Ivanetich and Goold, 1989). In addition, these investigators
suggested that the kinetic mechanism of the GST is isoenzyme-
dependent. Some isoenzymes (for example rat's YaYa GST)
appear to follow conventional hyperbolic kinetics while others
(for example rat's 2-2, 3-3, 3-4 GSTs) exhibit non-hyperbolic
kinetics (Schramm et al., 1984; Ivanetich et al., 1990). The
steady-state random sequential Bi Bi mechanism may be
sufficient to explain this phenomenon in rat hepatic GST
isoenzymes (Ivanetich et al., 1990). Phillips and Mantle
(1991) reported that by using a computer simulation program
(EKPLOT) a model was developed that suggested the presence of
an allosteric site on mouse GST YfYf. Perhaps this
allosterism accounts for the deviation from hyperbolic
kinetics.
There appears to be little work reported on human hepatic
glutathione s-transferases. In some respects this is
surprising since these forms of GST have received considerable
interest as possible early markers for hepatocellular toxicity
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1985a; Beckett et al..and carcinogenicity (Beckett et al.,
1989a; Beckett et al., 1989b; Hayes et al., 1990; Hussey et
al., 1986; Hayes et al., 1988; Sherman et al., 1983; Beckett
et al., 1987; Sherman et al., 1983; Beckett et al., 1985b; Gow
et al., 1987). Hence, the aims of this study are to purify
glutathione s-transferase from human hepatoma cells and to
elucidate the kinetic parameters of human hepatic GST. The






Untreated human hepatoma cells (cell line HEP-G2) were
purchased from the American Type Culture Collection. The HEP-
G2 cells were incubated (in 5% CO2) in sterile 75cm^ flasks at
37°C in Dulbecco Modified Eagle's Medium with 4.5g/L glucose
supplemented with 10% Fetal Bovine Serum and an Antibiotic-
Antimycotic mix (penicillin, streptomycin and amphotericin B).
The cells were kept in log phase by weekly subculture.
Subculture
Subculturing entailed decanting the medium and washing
the cells twice with 5 ml Hanks Balanced Salt Solution. The
salt solution was decanted and the cells Incubated with 2.5 ml
Trypsin/EDTA for 2-5 min. for cell detachment. The cells were
then transferred to a sterile culture tube and centrifuged at
approximately 1000 xg for 4 min. The supernatant was decanted
and the pelleted cells were resuspended in 2 ml Dulbecco
Modified Eagle's Medium. The cells were allguoted, 0.2 ml per
10 ml medium, into culture flasks.
15
Harvest
The medium was decanted by aspiration. The cells were
washed twice with 5 ml (4°C) saline. The saline solution was
decanted and 0.5 ml of 0.01 M potassium phosphate buffer with
0.1% KCl (pH 7.3) was added to the flask. The cells were
detached from the flasks' surface with a rubber policeman and
homogenized using a motor driven pestle. The homogenate was
centrifuged at 10,000 xg in a Beckman J2-21 centrifuge at 4°C
for 30 minutes. The supernatant was decanted and stored at
-70°C until needed.
Purification of GST from HEP-G2 Cells
HEP-G2 cells were grown in culture to provide a source of
GST. The cells were harvested and homogenized on ice at 4°C.
The homogenate was concentrated to a volume of 1 ml via an
Amicon ultrafiltration unit. The 1 ml sample was layered on
a glutathione-agarose affinity column and eluted with three
buffers: (A) 10 mM Tris HCl, pH 8, (B) 10 mM Tris HCl, pH 8,
with 5mM GSH, (D) 10 mM Tris HCl, pH 8, with 0.1 M KCl. The
eluent containing 0.1 M KCl was dialyzed against buffer A
using the Spectra/Pore molecular porus membrane with a
molecular weight cut-off of 6000-8000 daltons. The eluents
and dialysate were then concentrated to 5 ml via
ultrafiltration. The protein content of the samples were
determined by means of BioRad's microprotein assay.
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Protein Assay
Briefly, 0.8 ml of standards (known quantities of Bovine
Serum Albumin) and appropriately diluted samples were placed
in clean, dry test tubes. The "blank" consisted of 0.8 ml
sample buffer. The contents of each test tube was vortexed,
avoiding excess foaming, following the addition of 0.2 ml
BioRad's dye reagent concentrate. After an incubation period
of 15 min. at room temperature, the ODggg versus the reagent
blank was determined using the Beckman DU-8 Spectrophotometer.
A standard plot of OD^g^ versus concentrations of standards
was generated from which the concentrations of the unknown
samples was determined.
Assessment of Kinetic Mechanism
A GST enzyme assay was executed according to Corrigall et
al., (1989). The reaction mixture contained 3.33 mM potassium
phosphate with 0.1% KCl (pH 7.2), 0.5 ug GST, and the primary
(reduced glutathione; GSH) and secondary (l-chloro,2,4-
dinitrobenzene; CDNB) substrates. One substrate was varied
between 1.00 mM - 2.00 mM while the other was held at a
constant concentration while maintaining the final volume of
the reaction mixture at 3 ml. This series of experiments were
repeated by alternating the constant and variable substrates.
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The optical density was determined at 340 nm (absorbance
maximum of the product) with a Beckman DU-64 Spectrophotometer
equipped with a kinetics compuset module. This
spectrophotomer has the capacity to take absorbance
measurements at time intervals as small as 3 seconds. The
initial rates of reaction were monitored in 12 seconds at
25°C.
Determination of the Composition of GST
SDS-PAGE was employed to assess GST subunits according to
the method of Laemmli (1970). Fifteen milliliters (15 ml) of
deionized 30% acrylamide:bisacrylamide (29:1) was mixed with
15 ml of 1.5 M Tris base (pH 8.8 with HCl) containing 0.4%
(v/v) SDS and lOOuL of ammonium persulfate (100 mg/ml made on
the day of use) . The volume was brought to 60 ml with
deionized water. This yielded a 7.5% gel. Thirty microliters
(30 uL) N,N,N^,N^-Tetramethylethylenediamine (TEMED) were
added to catalyze polymerization. Bio-Rad's Protean II xi gel
electrophoresis cell was utilized and the manufacturer's
Instructions were followed for assembly. The 60 ml
unpolymerized gel mix was poured into the prepared plates and
gently layered with a few milliliters of saturated butanol/H20
to form a flat surface while the acrylamide polymerized.
After one hour, the butanol/H2O was decanted, and a top
"stacking" gel [1 ml 30% acrylamide/bisacrylamide, 4 ml H2O,
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5 ml 0.25 M Tris, pH 6.8, 0.2% (v/v) SDS, 100 uL ammonium
persulfate, 7 uL TEMED] was poured to fill the upper 3 cm of
the gel. The well-forming comb was inserted and the
stacking gel was allowed to polymerize. The gel was attached
to the electrophoresis unit and approximately 1.5 L IX
electrode buffer [0.025 M Tris base with 14.4 g glycine, 0.1%
(v/v) SDS] was added to the bottom chamber and 500 ml was
added to the top chamber. Ten microliters (10 uL) samples
(1-100 ug protein) were mixed with 10 uL of 2X sample buffer
[0.125 M Tris, pH 6.8, 4% (v/v) SDS, 10% glycerol, 0.02% (w/v)
bromophenol blue, 5% (v/v) B-mercaptoethanol]. The mixture
was then heated to 95°C for 3 min. and loaded on the gel. The
molecular weight standards, which were treated identically as
the sample, were then loaded on the gel. Electrophoresis
began at a constant 100 volts and continued until the dye
front approached the terminus of the gel. After
electrophoresis, the gel was removed from the unit and stained
for at least 30 minutes with 0.1% Coomassle Blue in fixative
(40% methanol, 10% acetic acid). The gel was then destained




Glutathione S-transferase was purified from HEP-G2 human
hepatoma cells by affinity chromatography on cross-linked 4%
beaded epoxy-activated agarose with Insolubullzed GSH. The
9,000 X g supernatant extract from these cells was applied to
a 20 cm X 1.5 cm affinity column, which was eluted step-wise
with three buffers (Buffers A, B, and D) . Figure 4 depicts a
typical elution profile.
Elution of the column with buffers B and D resulted in
the detection of two putative forms of GST, identified as low-
affinity (fraction B) and high-affinity forms (fraction D).
This designation was given to the peaks because of the
relative ionic strength of the buffers needed to elute each
form.
During a typical purification protocol, fraction A
represented 84% of the soluble cytosolic protein placed on the
column while fractions B and D represented 0.64% and 0.35%,
respectively (Table 2). Thus, the GST isoenzymes comprised
less than one percent of the total recovered cytosolic
proteins.
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FIGURE 4; Elution profile of glutathione s-transferase.
HEP-G2 supernatant was loaded on a glutathione-
agarose affinity column. The column was eluted




ABSORBANCE(280nm) BuffarA Buffer BufferD 1
TABLE 2: Glutathione s-transferase purification.









Fraction A 514.62 - 84.0
Fraction B 62,907.42 36.10 0.64
Fraction D 162,769.64 93.41 0.35
yield of total protein from the 9,000 x g supernatant was
determined by successive protein assays at each purification
step.
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Both fractions B and D exhibited GST activity with the
substrates CDNB and GSH (Table 2) while specific activity with
DCNB and GSH was negligible (data not shown). Since fraction
D possessed the greatest amount of GST activity it was used as
the source of enzyme in subsequent studies.
Electrophoretic Analysis of Purified GST
The electrophoretic mobility of glutathione s-transferase
was examined and the molecular weight of both forms of GST was
determined via SDS-PAGE as described by Laemmll (1970). The
stacking gel and the separating gel concentrations were 3% and
7.5%, respectively. Phosphorylase b (106,000 daltons). Bovine
Serum Albumin (80,000 daltons). Ovalbumin (49,500 daltons) and
Carbonic anhydrase (32,500 daltons) were used as standards for
characterization of molecular size. The low-affinity
Isoenzyme studied yielded a single band of 47,969 daltons as
compared to the protein markers. The high-affinity Isoenzyme
studied yielded a band of 45,115 daltons in addition to a
second band of 75,218 daltons as compared to the protein
markers (Fig. 5).
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Figure 5: Sodium Dodecyl Sulfate Polyacrylamide Gel. The
electrophoretic mobility of the GST isoenzymes
were analysed via SDS-PAGE. The gel consists of
7.5% separating gel and 3% stacking. Lane 1
displays the high affinity GST isoenzymes
(fraction D); lane 2 displays the low affinity
GST Isoenzymes (fraction B); lane 3 displays
fraction A; lane 4 displays the 9,000 x g












Determination of Optimal Assay Conditions
In order to determine the optimal conditions under which
the enzyme would exhibit maximal activity, the substrate
concentrations and pH of the reaction mixture (3.33 mM
potassium phosphate with .1% KCl, 1 mM GSH, 5 mM CDNB, GST,
dH20 to final volume of 3 ml) were varied. The pH profile
(Fig. 6) revealed that enzyme activity is maximal at pH 7.2.
The CDNB profile (Fig. 7) reveals that activity is
maximal at a 5 mM concentration. Linearity was lost above
concentrations of 5 mM CDNB. However, at physiological pH
(7.2) and 5 mM CDNB, the reaction appeared to remain linear
from 1 itiM GSH - 3 mM GSH (Fig. 8).
Another study involved varying the amount of GST in the
assay. Figure 9 shows that the amount of activity increased
with increasing amounts of GST and plateaued at approximately
1.4 ug protein. The optimal conditions for kinetic analysis
were hence defined as 5 mM CDNB and 3 mM GSH representing
saturating substrate levels, pH 7.2, and 0.5 ug GST. These
conditions were maintained throughout all kinetic assays.
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FIGURE 6: Glutathione s-transferase activity with
varying pH. Specific activity is measured over a

























FIGURE 7; Glutathione s-transferase activity with
varying CDNB concentrations. Activity was


































FIGURE 9; Glutathione s-transferase activity with varying
GST (fraction D) amounts. Fraction D was assayed
following dialysis to remove excess salt.
VELOCITY(rwnel/mtrO
Kinetic Analysis
The initial rate kinetics with varying CDNB gave a
pattern of intersecting lines which met near the abscissa of
the double reciprocal plot (Fig. 11). Analysis of the
experimental data in terms of the initial rates gave a
Michaelis constant (Kj^^) value of 2.502 mM ± 0.003 mM in the
absence of the inhibitor (Figs. 10 and 11). The apparent Km
value for varying GSH is 1.611 mM ± 0.548 mM in the absence of
the inhibitor (Figs. 12 and 13). The maximal rate of
catalysis was 0.188 nmol/min ± 0.032 nmol/min for varying GSH
and 0.042 nmol/min ± 0.025 nmol/min for varying CDNB in the
absence of the inhibitor (Figs. 11 and 13). Inhibition
studies were also conducted. Initial rates were recorded in
the presence of the inhibitor, 0.6 mM hydroquinone (HQ) also
known as 1,4-benzenedlol. In separate experiments, incubation
of hydroquinone in the absence and presence of enzyme did not
result in the loss of hydroquinone. Hence, there is no
enzymatic or non-enzymatic hydrolysis of hydroquinone. The
Michaelis constant, in the presence of HQ, for varying GSH was
0.391 nmol/min ± 0.042 nmol/min (Figs. 12 and 13). The
apparent Kj^^ value for varying CDNB in the presence of
hydroquinone was 2.514 nmol/min ± 0.124 nmol/min (Figs. 10 and
11). The maximal catalytic rates, while varying CDNB and GSH
in the presence of hydroquinone, were 0.013 nmol/min ± 0.005
nmol/min and 0.083 nmol/min ± 0.002 nmol/min, respectively
(Figs. 11 and 13; refer to Table 3 for kinetic parameters).
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FIGURE 10: Hyperbolic plot of GST (D) initial velocity v/s
varying CDNB concentrations, with 3 mM GSH
remaining constant, in the presence (closed





FIGURE 11: Lineweaver-Burk plot of GST (D) initial
velocity v/s varying CDNB concentrations, with
3 mM GSH remaining constant. In the presence





FIGURE 12: Hyperbolic plot of GST (D) initial velocity v/s
varying GSH concentrations, with 5 itiM CDNB
remaining constant, in the presence (closed




FIGURE 13: Lineweaver-Burk plot of GST (D) Initial velocity
v/s varying GSH concentrations, with 5 mM CDNB
remaining constant, in the presence (open




TABLE 3: Glutathione s-transferase (high affinity form)
kinetic parameters.
KINETIC
PARAMETER SUBSTRATE +HYDROQUINONE -HYDROQUINONE
K„ (mM) GSH 0.391 + 0.042 1.611 + 0.548
V
(nmol/min)
GSH 0.083 ± 0.002 0.188 + 0.032
K„ (mM) CDNB 2.514 + 0.124 2.500 ± 0.003
V_
(nmol/min)
CDNB 0.013 + 0.005 0.042 + 0.005
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In addition, the ratio of the Michaelis constants
in the absence of hydroquinone does not
significantly deviate from unity. These studies suggest,





Chemoresistance is a primary concern regarding many
diseases including antibiotic-resistant tuberculosis, sexually
transmitted diseases and cancer treatment failure. During
this phenomenon, tumors are rendered non-responsive to the
therapeutic effects of anti-cancer agents. As such, many
preneoplastic and neoplastic lesions progress to malignancy.
Chemoresistance is complex and multiple mechanisms may be
underlying this phenomenon. One form of chemoresistance is
that of multi-drug resistance (Rodriguez et al., 1993;
Ishikawa et al., 1993). In such a system, a 170 kilodalton
phospho-glycoproteln (P-GP) acts as an active pump reducing
the intracellular drug concentration (Rodriguez et al., 1993).
Another proposed mechanism of chemoresistance suggests
that altered DNA topolsomerase activity results in enzymatic
DNA cleavage in the presence of some antitumor agents. The
antitumor agent does not block normal topolsomerase activity,
but rather complexes with the topolsomerase subverting it in
such a way as to render the enzyme a lethal Instrument (Ross,
1985; Moscom and Cowan, 1988). Hence, the enzyme becomes a
required co-factor for required drug action. The existing
topolsomerase-drug complex has the capacity to cleave DNA
molecules (Ross, 1985; Moscom and Cowan, 1988).
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Induction of the GST genes have also been implicated in
chemoresistance. As such, this gene and its product have been
the topic of intense research in tumor cells. It has been
shown that preneoplastic and neoplastic liver lesions display
features different from those of normal liver cells in rats
(Rao et al., 1992; Sato, 1989). These features include the
loss of some normally present enzymes such as glucose 6-
phosphatase, ATPase, and some phase I drug metabolizing
enzymes. In addition, these features also Include the
increased activity of particular enzymes; y-
glutamyltranspeptidase, ce-fetoprotein, glutathione s-
transferase, and other phase II drug metabolizing enzymes.
However, glutathione s-transferases have been reported as
reliable markers for preneoplastic lesions and neoplastic
tissues in the liver, as well as in other organs in rat and
other species, including man (Sato, 1989; Rao, 1992).
This study has revealed the presence of multiple forms
of GST, a high affinity and a low affinity form. The
relevance of these cytosolic forms are still speculative.
However, this phenomenon is not unique to human physiology as
is seen in the redundance of the wobble code, overlapping
hormonal activity, and the variety of immunogloblns comprising
the humoral immune response. The presence of these forms of
GST may result in a more versatile response and; perhaps, a
more enhanced response to oxidative insults that may threaten
the integrity of the cell. It is interesting to note that the
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high affinity form is also the more active form and hence the
more efficient form of GST but comprises less than half of the
recovered forms of GST. In such a system, the more active
form of GST would provide an immediate but brief response to
oxidative insults whereas the less active form may provide a
later but more sustained response to insults.
Multiple forms of GST may have another relevant role in
hepatocytes. It is conceivable that, perhaps, one form may be
more active under conditions that hinder the other. According
to Lehninger (1975), the solubility of proteins can be
influenced by pH. The minimal pH at which the protein remains
soluble is referred to as that protein's isoelectric pH or
Isoelectric point (pi). At this point (pi) of minimal
solubility one would also expect minimal activity. Hence, an
enzyme would be least active at its isoelectric point.
Considering fig. 6, the isoelectric point of the high affinity
form is near neutral (pH 7). We also noted a sharp and steady
decrease in activity at pH < 6.6 and pH > 7.3. This occurrence
is probably due to protein denaturation. Jagt et al., (1985)
isolated and characterized a high affinity form of GST, which
they refer to as having specific activity of 146±8
imol/min/mg and pi of 6.19. These values are in reasonable
agreement with our findings. They also report isolating a low
affinity form of GST which they refer to as form III, with
specific activity 62 + 1 |jBiol/min/mg with pi 8.72. Again, the
activity of this form is in agreement with our findings.
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Hence, it appears that the low affinity form is capable of
activity under conditions which would compromise the activity
of the high affinity form.
The electrophoretic behavior of both forms of GST yielded
unique results. GST has been shown to be dimers of
approximately 27 kd on an electrophoretic gel (Jagt et al.,
1985). Jagt et al., have shown both forms of GST existing as
a single band of approximately 27 kd on an electrophoretic
gel. SDS-PAGE have resolved our GST samples as single bands
comigrating with the 42 kd molecular weight marker. An
additional protein, approximately 75 kd, co-purlfied with the
high affinity form. Densitometric scans suggest that this
protein comprises 15% of this sample (Area count = 2.55E-13
nm^.; data not shown). Modification of the electrophoretic
conditions; 1-5% SDS, 1-5% p-mercaptoethanol, 1-5%
dithiotrietol, heated sample between 90°C-100°C for 5-45
minutes, did not alter the electrophoretic behavior of the
isolated GST. The discrepancy in the molecular weight may be
due to the source of GST. Jagt and his colleagues obtained
normal human liver samples at autopsy from an adult female who
died from accidental causes. Our samples were obtained from
human hepatoma cells in culture. The proteins from these
tumor cells may have been structurally altered resulting in
abnormal structural stability. This occurrence would account
for the seemingly monomeric behavior of GST.
Kinetic analyses were limited to the partially purified
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high-affinity isoenzymes since this form (fraction D) was most
active with the substrate CDNB. The apparent Kj^ for varying
CDNB in the absence of the inhibitor, hydroquinone (HQ), was
2.50 mM (See Table 3 for kinetic parameters). The maximal
rate of catalysis was 0.042 nmol/min. In the presence of HQ,
the apparent Kjjj was unchanged, 2.51 mM, while was 0.013
nmol/min. The intersection of both curves occur on the
abscissa and is indicative of noncompetitive inhibition in the
presence of hydroquinone. The possible enzyme forms present
may be represented as E, El or ESI, where El is analogous to
the enzyme-inhibitor complex and ESI is analogous to the
enzyme-inhibitor-CDNB complex. These forms complexed to the
inhibitor exhibited reduced activity. The unchanging Kjjj value
indicated that the enzyme forms present (E & El), which can
combine with CDNB, have equal affinities for CDNB (Segel,
1975). The apparent Kjjj value, therefore, results from the
distribution of available enzyme between the "full affinity"
and "no affinity" forms (Segel, 1975).
The apparent Kjj^ value for varying GSH was 1.61 mM while
the maximal rate was 0.18 nmol/min in the absence of HQ. The
inhibitor reduced the rate, 0.08 nmol/min., for product
formation while markedly Increasing the affinity, 0.039
mM, of the enzyme for the substrate. The plots (Fig. 13)
Intersect above the 1/[S] axis at a point greater than 1/V__„,
and a positive 1/[S] value unlike that of competitive or
noncompetitive inhibition. The ESI/EI equilibria is
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suggestive of a system displaying partial uncompetitive
inhibition; however, the reciprocal plots are not parallel.
This phenomenon is indicative of mixed-type inhibition (Segel,
1975).
The ratio of the Michaelis constants in
the absence of hydroquinone does not significantly deviate
from unity. This occurrence may suggest that the interaction
between the primary substrate (S^) and the unbound enzyme (E)
does not significantly influence the interaction between the
complex (E-Sj^) and the secondary substrate. Hence,
cooperativity appears to be negligible.
Cumulatively, these occurrences suggest a random
interaction of GST with its substrates and possibly sequential
binding of these substrates. The high affinity isoenzymes
apparently possess multiple catalytic forms since random
interaction with its substrates is preferential. This
phenomenon may further be supported by the appearance of
multiple ionic forms in which catalytic activity is maintained
(Fig. 6). An effective therapeutic agent should be able to
interact with these forms. In addition, aromaticity appears
to be unimportant in terms of GST interaction, since
negligible activity resulted with DCNB. This occurrence




Many chemotherapeutic agents are inactivated by
glutathione s-transferase. Hence, these carcinostatic
compounds may serve as potential substrates of GST and, as
such, are rendered ineffective. The concept of drug overdose
to compensate for potential drug detoxication is inefficient
since many of these carcinostatic compounds induce deleterious
side effects. The kinetic analysis of GST in human hepatoma
cells may represent a convenient method of determining topical
relationships/interactions with its substrates. As such,
tumors may be sensitized to the effects of the chemoprotectant
by minimizing GST activity.
This study has shown evidence of the random Interaction
of substrates with GST. Aromaticity appears to be unimportant
in GST's activity. The presence of multiple forms of
cytosolic GST may comprise an adaptive biotransformation
system capable of responding to oxidative insults which may
compromise the integrity of the cell. In addition, these
enzymes appear to be more structurally stable in tumor
hepatocytes than normal hepatocytes.
These findings may elucidate plausible mechanisms of
drug-protein interaction and ultimately drug design. These
studies, coupled with other electronic and stereospecific




Abramovitz, M. and Listowsky, I. 1987. Selective expression
of a unique glutathione s-transferase ¥^3 gene in rat
brain. The Journal of Biological Chemistry. 262:7770-
7773.
Adams, P. A., and Sikakana, C. N. T. 1990. Factors affecting
the inactivation of human placental glutathione s-
transferase. Biochemical Pharmacology. 39:1883-1889.
Al-Kassab, S., Boyland, E. and Williams, K. 1963. An enzyme
from rat liver catalyzing conjugations with glutathione.
Biochemical Journal. 87:4-9.
Awasthi, Y., Bhatnagar, A. and Singh, S. 1987. Evidence for
the Involvement of histidine at the active site of
glutathione s-transferase from human liver. Biochemical
and Biophysical Research Communications. 143:965-970.
Barnes, M. M., James, S. P., and Wood, P. B. 1959. The
formation of mercapturlc acids. 1. Formation of
mercapturic acids. 1. Formation of mercapturlc acid and
the levels of glutathione in tissues. Biochemical
Journal. 87:4-10.
Beckett, G. J., Chapman D. J., Dyson, E. H. and Hayes, J. D.
1985a. Plasma glutathione s-transferase measurements
following paracetmol overdose: evidence for early
hepatocellular damage. Gut. 26:26-31.
Beckett, G. J., Foster, G. R., Hussey, A. J., Oliveira, D. B.
G., Donovan, J. W., Prescott, L. F. and Proudfoot, A. T.
1989a. Plasma glutathione s-transferase and F protein
are more sensitive than alanine aminotransferase as
indicators of paracetamol (acetaminophen)-induced liver
damage. Clinical Chemistry. 35:2186-9.
Beckett, G. J., Hayes, P. C., Hussey, A. J., Bouchier , I. A.
D. and Hayes J. D. 1987. Plasma glutathione s-
transferase measurements in patients with alcoholic
cirrhosis. Clinica Chimica Acta. 169:85-90.
Beckett, G. J., Hussey, A. J., Lalng, I. Howie, A. F., Hayes,
J. D., Strange, R. C., Faulder, C. G., and Hume, R.
1989b. Measurement of glutathione s-transferase B^^ in
plasma after birth asphyxia: an early Indication of
hepatocellular damage. Clinical Chemistry. 35:995-9.
44
BeckG't't/ G. J*/ Ksllett, H. A./ GoWf S« M./ Gow^ S< M./
Hussey, A. J., Hayes J. D. and Toft, A. D. 1985b.
Raised plasma glutathione s-transferase values in
hyperthyroidism and in hypothyroid patients receiving
thyroxine replacement: evidence for hepatic damage,
British Medical Journal. 291:427-31.
Booth, J., Boyland, E. and Sims, P. 1961. An enzyme from rat
liver catalyzing conjugations with glutathione.
Biochemical Journal. 79:516-524.
Boyland, E. and Chasseaud, L. 1969. The role of glutathione
and gluththione s-transferases in mercapturic acid
biosynthesis. Advances in Enzymology. 32:173-219.
Brand, E. and Harris, M. M. 1933. Some aspects of
intermediary protein metabolism. Science. 77:589.
Bray, H. G., Franklin, T. J., and James, S. P. 1959. The
formation of mercapturic acids. 2. The possible role of
glutathione. Biochemical Journal. 71:690.
Chasseaud, L. F. 1974. Glutathione S-Transferases. in:
Glutathione, edited by Flohe, L., Benohr, H. C., Sles,
H., Waller, H. D., Wendel, A. Academic Press, INC. New
York. pp. 90-108.
Chasseaud, L. F. 1979. The role of glutathione and
glutathione s-transferases in the metabolism of chemical
carcinogens and other electrophilic agents. Advances in
Cancer Research. 29:175-274.
Corrigall, AnneV., Bhargava, MadhaM., Ivanetich, Kathryn M.,
Ehlers, Mario R, W. and Kirsh, Ralph E. 1989. site-
directed inactivation of human lung acidic glutathione s-
transferase by l-chloro-2,4-dinitrobenzene in the absence
of glutathione. Blochimlca et Biophy^ica Acta. 991:399-
404.
Danielson, U. H. and Mannervik, B. 1988. Paradoxical
inhibiton of rat glutathione transferase 4-4 by
indomethacin explained by substrate-inhibitor-enzyme
complexes in a random-order sequential mechanism.
Biochemical Journal. 250:705-711.
Davis, D. L. 1989. Natural anticarcinogens, carcinogens, and
changing patterns in cancer: some speculation.
Environmental Research. 50:322-340.
45
Ding, G., Lu, A. and Pickett, C. 1985. Rat liver glutathione
S-transferases; nucleotide sequence analysis of a Yb,
cDNA clone and prediction of the complete amino acid
sequence of the Ybi subunit. The Journal of Biological
Chemistry. 260:13268-13271.
Gow, S. M., Caldwell, G., Toft, A. D., Seth, J., Hussey, A.
J., Sweeting, V. M. and Beckett, G. J. 1987.
Relationship between pituitary and other target organ
responsiveness in hypothyroid patients receiving
thyroxine replacement. Journal of Clinical Endocrinology
and Metabolism. 64:364-70.
Grover, P. L., and Sims, P. 1964. Conjugations with
glutathione: distribution of glutathione s-
aryltransferase in vertebrae species. Biochemical
Journal. 90:603-604.
Habig, W. H., and Jakoby, W. B. 1981. Glutathione s-
transferases (rat and human). Methods in Enzymology.
77:218-231.
Hayes, P. C., Bouchier, I. A. D. and Beckett, G. J. 1991.
Glutathione s-transferase in humans in health and
disease. Gut. 32:813-818.
Hayes, P. C., Hayes, J. D., Hussey A. J., Bouchier, I. A. D.
and Beckett, G. J. 1990. Changes in plasma glutathione
s-transferase Bj^ concentration after alcohol ingestion in
man: a measure of hepatocellular sensitivity to chronic
alcohol excess. Clinical Chemistry and Enzymology
Communications. 2:189-94.
Hayes, P. C., Hussey, A. F., Keating, J., Bouchier, I. A. D.,
Williams, R., Beckett, G. J. and Hayes, J. D. 1988.
Glutathione s-transferase levels in autoimmune chronic
active hepatitis; a more sensitive index of
hepatocellular damage than aspartate aminotransferase.
Clinica Chimica Acta. 172:211-6.
Hussey, A. J., Howie, J. J., Allan, L. G., Drummond, H.,
Hayes, J. D. and Beckett, G. J. 1986. Impaired
hepatocellular integrity during general anaesthesia as
assessed by measurement of plasma glutathione s-
transferase. Clinica Chimica Acta. 161:19-28.
46
Ishikawa, H., Kawano, M. M., Okada, K., Tanaka, H., Osamu, T.,
Sakai, A., Asaoku, H., Iwato, K., Nobuyoshi, M.,
Kuramoto, A. 1993. Expressions of DNA topoisomerase I
and II gene and the genes possibly related to drug
resistance in human myeloma cells. British Journal of
Haematology. 83:68-74.
Ivanetich, K. M. and Goold, R. D. 1989. A rapid equilibrium
random sequential bi-bi mechanism for human placental
glutathione s-transferase. Biochimica et Biophysica
Acta. 998:7-13.
Ivanetich, K. M., Goold, R. D. and Sikakana, C. N. T. 1990.
Explaination of the non-hyperbolic kinetics of the
glutathione s-transferases by the simplest steady-state
random sequential bi bi mechanism. Biochemical
Pharmacology. 39:1999-2004.
Jagt, D. L. V., Hunsaker, L. A., Garcia, B. K., and Royer, R.
E. 1985. Isolation and characterization of the multiple
glutathione s-transferases from human liver. The Journal
of Biological Chemistry. 260(21):11603-11610.
Jakoby, William B. 1980. Glutathione transferases.
Enzymatic basis of detoxication, edited by: Jakoby, W.
and Habig, W. Academic Press, New York. Vol. II; pp.
63-94.
Jakoby, W. B., Ketterer, B. and Mannervik, B. 1984.
Glutathione transferases: nomenclature. Biochemical
Pharmacology. 33(16): 2539-2540.
Keen, J., Habig, W. and Jakoby, W. 1976. Mechanism for the
several activities of the glutathione s-transferases.
The Journal of Biological Chemistry. 251:6183-6188.
Kong, K.-H., Takasu, D., Inoue, H., and Takahashi, K. 1992.
Tyrosine-7 in human class Pi glutathione s-transferase is
important for lowering the pK^^ of the thiol group of
glutathione in the enzyme-glutathione complex.
Biochemical and Biophysical Research Communications.
184:194-197.
Laemmli, U. K. 1970. Cleavage of structural proteins during
the assembly of the head of bacteriophage T4. Nature.
227:680-686.
Lai, H., Li, N., Weiss, M., Reddy, C. and Tu, C. 1984. The
nucleotide sequence of a rat liver glutathione s-
transferase subunit cDNA clone. The Jouimal of
Biological Chemistry. 259: 5536-5542.
47
Lai, H., Quian, B., Grove, G. and Tu, C. 1988. Gene
expression of rat glutathione s-transferases: evidence
for gene conversion in the evolution of the Yb multigene
family. The Journal of Biological Chemistry. 263:11389-
11395.
Lehninger, Albert L. Biochemistry. 2*^^ ed. Worth Publishers
INC., New York. 1975.
Mannervik, B., Alin, P., Guthenberg, C., Jensson, H., Tahir,
M. K., Warholm, M., and Jornvall, H. 1985.
Identification of three classes of cytosolic glutathione
transfersase common to several mammalian species:
correlation between structural data and enzymatic
properties. Proceedings of the National Academy of
Science. 82:7202-7206.
Mannervik, B. 1985. The isoenzymes of glutathione
transferase. Advances in Enzymology. 57: 357-417.
Meikle, I., Hayes, J. D., Walker, S. W. 1991. Expression of
an abundant ce-class glutathione S-transferase in bovine
and human adrenal cortex tissues. Journal of
Endocrinology. 132:83-92.
Meister, A. 1980. A brief history of glutathione and a
survey of its metabolism and functions. Glutathione;
chemical, biochemical and medical aspects. Part A.
edited by: Dolphin, D., Poulson, R., Avramovlc, 0. John
Wiley & Sons, New York. pp. 1-48.
Miller, J. A. 1970. Carcinogenesis by chemicals: an
overview--G. H. A. Clowes memorial lecture. Cancer
Research. 30:559-576.
Miller, J. and Miller, E. 1971. Chemical carcinogenesis:
mechanisms and approaches to its control. Journal of the
National Cancer Institute. 47;v - xiv.
Mills, G. C., and Wood, J. L. 1956. Mercapturlc acid
precursors. Journal of Biological Chemistry. 219:1-6.
Moscow, J. A. and Cowan, K. H. 1988. Multidrug Resistance.
Journal of the National Cancer Institute. 80(1):14-20.
Phillips, M. F., and Mantle, T. J. 1991. The initial-rate
kinetics of mouse glutathione s-transferase YfYf.
Biochemial Journal. 275:703-709.
48
Pickett, C. B. 1989. Glutathione s-transferases; gene
structure, regulation, and biological function. Annual
Review of Biochemistry. 58:743-764.
Pickett, C. B., Telakowski-Hopkins, C., Ding, J., Argenbright
and L. Lu, A. 1984. Rat liver glutathione s-
transferases: complete nucleotide sequence of a
glutathione s-transferase mRNA and the regulation of the
Ya, Yb, and Yc mRNAs by 3-methylcholanthrene and
phenobarbital. The Journal of Biological Chemistry.
259:5182-5188.
Preussmann, R. 1976. Chemical carcinogens in the human
environment problems and quantitative aspects. Oncology.
33:51-57.
Rao, M. S., Subbarao, V. Kumar, S. Yeldandi, A. B. Peddy, J.
K. 1992. Phenotypic properties of liver tumors induced
by dehyroepiandrosterone in F-344 rats. Japanese Journal
of Cancer Research. 83:1179-1183.
Rodriguez, C., Commes, T., Robert, J., Rossi, J. 1993.
Expression of P-glycoprotein and anionic glutathione s-
transferase genes in non-hodgkln's lymphoma. Leukemia
Research. 17(2):149-156.
Ross, W. E. 1985. DNA topoisomerases as targets for cancer
therapy. Biochemical Pharmacology. 34(24):4191-5.
Sato, K. 1989. Gluthathlone transferases as markers of
preneoplasia and neoplasia. Advances in Cancer Research.
52:205-255.
Schasteen, C., Krlvak, B. and Reed, D. 1983. Similarities in
inactivation of glutathione s-transferases by arginine
specific chemical modifying agents. Federation
Proceedings. 42: #1631.
Schramm, V. L. McCluskey, R., Emlg, F. A. and Litwack, G.
1984. Kinetic studies and active site binding properties
of glutathione s-transferase using spin-labeled
glutathione, a product analogue. The Journal of
Biological Chemistry. 259:714-722.
Segel, I. H. Enzyme Kinetics; Behavior and Analysis of
Rapid Equilibrium and Steady-State Enzyme Systems.
Wiley-Interscience Publication. New York, 1975.
Sherman, M., Bass, N. M., Campbell, J. A. H. and Kirsch R. E.
1983. Radioimmunoassay of human ligandin. Hepatology.
3:162-169.
49
Smith, J. N., Spencer, B., and Williams, R. T. 1950. Studies
in detoxication. 34. The metabolism of chlorobenzene in
the rabbit. Isolation of dihydrodihydroxychlorobenzene,
p-chloro-phenylglucuronide, 4-chlorocatechol glucuronide
and p-chlorophenylmercapturic acid. Biochemical Journal.
47:284.
Stekol, J. A. 1939. Studies on the mercapturic acid
synthesis in animals. XI. The detoxication of benzyl
chloride, benzyl alcohol, benzaldehyde and S-
benzylhomocysteine in the rabbit and rat. Journal of
Biological Chemistry. 128:199.
Suguoka, Y., Kano, T., Okuda, A., Sakai, M., Kitagawa, T. and
Muramatus M. 1985. Cloning and the nucleotide sequence
of rat lutathione s-transferase P cDNA. Nucleic Acid
Research. 13:6049-6057.
Telakowski-Hopkins, C., Rodkey, J., Bennett, C., Lu, A. and
Pickett,C. 1985. Rat liver glutathione s-transferases:
construction of a cDNA clone complementary to a Yc mRNA
and prediction of the complete amino acid sequence of a
Yc subunit. The Journal of Biological Chemistry.
260:5820-5825.
Waelsch, H. 1930. Detoxication in the animal organism.
Archives of Experimental Pathology and Pharmakology.
156;356-360.
Wlslocki, P., Miwa, G. and Lu, A. 1980. Reactions catalyzed
by the cytochrome P-450 system. Enzymatic basis of
detoxication, (edited by: Jakoby, William B. Academic
Press, New York) Vol. I; pp 136-175.
50
